menu
    • menu

    Company profile for Cellectis

    NEW Drugs in Dev: 11
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. Cellectis is focused on addressing the medical and food needs of an ever-growing global population through the use of proprietary gene-editing technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellectisFrance Flag
    Country
    Country
    France
    Address
    Address
    8 rue de la Croix Jarry 75013 Paris
    Telephone
    Telephone
    +33 (0)1 81 69 16 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellectis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cellectis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cellectis?lang=fr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellectis to Hold Annual Shareholders Meeting on June 25, 2026
    Cellectis to Hold Annual Shareholders Meeting on June 25, 2026

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298898/0/en/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Cellectis Showcases Lasme-Cel And Eti-Cel Clinical Data At EHA
    Cellectis Showcases Lasme-Cel And Eti-Cel Clinical Data At EHA

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293001/0/en/cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Cellectis Reports Financial Results for the First Quarter 2026
    Cellectis Reports Financial Results for the First Quarter 2026

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292381/0/en/cellectis-reports-financial-results-for-the-first-quarter-2026.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Monthly Update: Share Capital & Voting Rights
    Monthly Update: Share Capital & Voting Rights

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289420/0/en/monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Cellectis To Release Q1 2026 Financial Results On May 11
    Cellectis To Release Q1 2026 Financial Results On May 11

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3287174/0/en/cellectis-to-report-first-quarter-financial-results-on-may-11-2026.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Cellectis Unveils Epigenetic Editing Platform At ASGCT Conference
    Cellectis Unveils Epigenetic Editing Platform At ASGCT Conference

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7212059

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search